Global Risperidone Market Insights, Forecast to 2028

Publisher Name :
Date: 07-Nov-2022
No. of pages: 111
Inquire Before Buying

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Risperidone is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Risperidone is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Risperidone is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key manufacturers of Risperidone include Janssen (Johnson & Johnson), Ajanta Pharma, Amneal Pharmaceuticals, Aurobindo Pharma, Hikma, Sandoz, Lannett, Tris Pharma and Apotex, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Risperidone manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Risperidone market. Further, it explains the major drivers and regional dynamics of the global Risperidone market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Janssen (Johnson & Johnson)

- Ajanta Pharma

- Amneal Pharmaceuticals

- Aurobindo Pharma

- Hikma

- Sandoz

- Lannett

- Tris Pharma

- Apotex

- Celltrion

- Dr. Reddy's Laboratories

- Torrent Pharmaceuticals

- Luye Pharma Group

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Risperidone Segment by Type

- Tablet

- Oral Solution

Risperidone Segment by Application

- Schizophrenia

- Bipolar Disorder

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Colombia

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Risperidone market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Risperidone, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Risperidone, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Risperidone, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Risperidone sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Risperidone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Risperidone sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Janssen (Johnson & Johnson), Ajanta Pharma, Amneal Pharmaceuticals, Aurobindo Pharma, Hikma, Sandoz, Lannett, Tris Pharma and Apotex, etc.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Risperidone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Risperidone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, sales and revenue for each segment.

Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.

Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.

Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.

Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Risperidone sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Global Risperidone Market Insights, Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Risperidone Product Introduction
1.2 Market by Type
1.2.1 Global Risperidone Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablet
1.2.3 Oral Solution
1.3 Market by Application
1.3.1 Global Risperidone Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Schizophrenia
1.3.3 Bipolar Disorder
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Risperidone Sales Estimates and Forecasts 2017-2028
2.2 Global Risperidone Revenue Estimates and Forecasts 2017-2028
2.3 Global Risperidone Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Risperidone Sales by Region
2.4.1 Global Risperidone Sales by Region (2017-2022)
2.4.2 Global Sales Risperidone by Region (2023-2028)
2.5 Global Risperidone Revenue by Region
2.5.1 Global Risperidone Revenue by Region (2017-2022)
2.5.2 Global Risperidone Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Risperidone Sales by Manufacturers
3.1.1 Global Top Risperidone Manufacturers by Sales (2017-2022)
3.1.2 Global Risperidone Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Risperidone in 2021
3.2 Global Risperidone Revenue by Manufacturers
3.2.1 Global Risperidone Revenue by Manufacturers (2017-2022)
3.2.2 Global Risperidone Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Risperidone Revenue in 2021
3.3 Global Risperidone Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Risperidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Risperidone Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Risperidone Sales by Type
4.1.1 Global Risperidone Historical Sales by Type (2017-2022)
4.1.2 Global Risperidone Forecasted Sales by Type (2023-2028)
4.1.3 Global Risperidone Sales Market Share by Type (2017-2028)
4.2 Global Risperidone Revenue by Type
4.2.1 Global Risperidone Historical Revenue by Type (2017-2022)
4.2.2 Global Risperidone Forecasted Revenue by Type (2023-2028)
4.2.3 Global Risperidone Revenue Market Share by Type (2017-2028)
4.3 Global Risperidone Price by Type
4.3.1 Global Risperidone Price by Type (2017-2022)
4.3.2 Global Risperidone Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Risperidone Sales by Application
5.1.1 Global Risperidone Historical Sales by Application (2017-2022)
5.1.2 Global Risperidone Forecasted Sales by Application (2023-2028)
5.1.3 Global Risperidone Sales Market Share by Application (2017-2028)
5.2 Global Risperidone Revenue by Application
5.2.1 Global Risperidone Historical Revenue by Application (2017-2022)
5.2.2 Global Risperidone Forecasted Revenue by Application (2023-2028)
5.2.3 Global Risperidone Revenue Market Share by Application (2017-2028)
5.3 Global Risperidone Price by Application
5.3.1 Global Risperidone Price by Application (2017-2022)
5.3.2 Global Risperidone Price Forecast by Application (2023-2028)
6 North America
6.1 North America Risperidone Market Size by Type
6.1.1 North America Risperidone Sales by Type (2017-2028)
6.1.2 North America Risperidone Revenue by Type (2017-2028)
6.2 North America Risperidone Market Size by Application
6.2.1 North America Risperidone Sales by Application (2017-2028)
6.2.2 North America Risperidone Revenue by Application (2017-2028)
6.3 North America Risperidone Market Size by Country
6.3.1 North America Risperidone Sales by Country (2017-2028)
6.3.2 North America Risperidone Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Risperidone Market Size by Type
7.1.1 Europe Risperidone Sales by Type (2017-2028)
7.1.2 Europe Risperidone Revenue by Type (2017-2028)
7.2 Europe Risperidone Market Size by Application
7.2.1 Europe Risperidone Sales by Application (2017-2028)
7.2.2 Europe Risperidone Revenue by Application (2017-2028)
7.3 Europe Risperidone Market Size by Country
7.3.1 Europe Risperidone Sales by Country (2017-2028)
7.3.2 Europe Risperidone Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Risperidone Market Size by Type
8.1.1 Asia Pacific Risperidone Sales by Type (2017-2028)
8.1.2 Asia Pacific Risperidone Revenue by Type (2017-2028)
8.2 Asia Pacific Risperidone Market Size by Application
8.2.1 Asia Pacific Risperidone Sales by Application (2017-2028)
8.2.2 Asia Pacific Risperidone Revenue by Application (2017-2028)
8.3 Asia Pacific Risperidone Market Size by Region
8.3.1 Asia Pacific Risperidone Sales by Region (2017-2028)
8.3.2 Asia Pacific Risperidone Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Risperidone Market Size by Type
9.1.1 Latin America Risperidone Sales by Type (2017-2028)
9.1.2 Latin America Risperidone Revenue by Type (2017-2028)
9.2 Latin America Risperidone Market Size by Application
9.2.1 Latin America Risperidone Sales by Application (2017-2028)
9.2.2 Latin America Risperidone Revenue by Application (2017-2028)
9.3 Latin America Risperidone Market Size by Country
9.3.1 Latin America Risperidone Sales by Country (2017-2028)
9.3.2 Latin America Risperidone Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Risperidone Market Size by Type
10.1.1 Middle East and Africa Risperidone Sales by Type (2017-2028)
10.1.2 Middle East and Africa Risperidone Revenue by Type (2017-2028)
10.2 Middle East and Africa Risperidone Market Size by Application
10.2.1 Middle East and Africa Risperidone Sales by Application (2017-2028)
10.2.2 Middle East and Africa Risperidone Revenue by Application (2017-2028)
10.3 Middle East and Africa Risperidone Market Size by Country
10.3.1 Middle East and Africa Risperidone Sales by Country (2017-2028)
10.3.2 Middle East and Africa Risperidone Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Janssen (Johnson & Johnson)
11.1.1 Janssen (Johnson & Johnson) Corporation Information
11.1.2 Janssen (Johnson & Johnson) Overview
11.1.3 Janssen (Johnson & Johnson) Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Janssen (Johnson & Johnson) Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Janssen (Johnson & Johnson) Recent Developments
11.2 Ajanta Pharma
11.2.1 Ajanta Pharma Corporation Information
11.2.2 Ajanta Pharma Overview
11.2.3 Ajanta Pharma Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ajanta Pharma Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ajanta Pharma Recent Developments
11.3 Amneal Pharmaceuticals
11.3.1 Amneal Pharmaceuticals Corporation Information
11.3.2 Amneal Pharmaceuticals Overview
11.3.3 Amneal Pharmaceuticals Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Amneal Pharmaceuticals Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Amneal Pharmaceuticals Recent Developments
11.4 Aurobindo Pharma
11.4.1 Aurobindo Pharma Corporation Information
11.4.2 Aurobindo Pharma Overview
11.4.3 Aurobindo Pharma Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Aurobindo Pharma Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Aurobindo Pharma Recent Developments
11.5 Hikma
11.5.1 Hikma Corporation Information
11.5.2 Hikma Overview
11.5.3 Hikma Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Hikma Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hikma Recent Developments
11.6 Sandoz
11.6.1 Sandoz Corporation Information
11.6.2 Sandoz Overview
11.6.3 Sandoz Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sandoz Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sandoz Recent Developments
11.7 Lannett
11.7.1 Lannett Corporation Information
11.7.2 Lannett Overview
11.7.3 Lannett Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Lannett Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Lannett Recent Developments
11.8 Tris Pharma
11.8.1 Tris Pharma Corporation Information
11.8.2 Tris Pharma Overview
11.8.3 Tris Pharma Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Tris Pharma Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Tris Pharma Recent Developments
11.9 Apotex
11.9.1 Apotex Corporation Information
11.9.2 Apotex Overview
11.9.3 Apotex Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Apotex Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Apotex Recent Developments
11.10 Celltrion
11.10.1 Celltrion Corporation Information
11.10.2 Celltrion Overview
11.10.3 Celltrion Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Celltrion Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Celltrion Recent Developments
11.11 Dr. Reddy's Laboratories
11.11.1 Dr. Reddy's Laboratories Corporation Information
11.11.2 Dr. Reddy's Laboratories Overview
11.11.3 Dr. Reddy's Laboratories Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Dr. Reddy's Laboratories Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Dr. Reddy's Laboratories Recent Developments
11.12 Torrent Pharmaceuticals
11.12.1 Torrent Pharmaceuticals Corporation Information
11.12.2 Torrent Pharmaceuticals Overview
11.12.3 Torrent Pharmaceuticals Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Torrent Pharmaceuticals Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Torrent Pharmaceuticals Recent Developments
11.13 Luye Pharma Group
11.13.1 Luye Pharma Group Corporation Information
11.13.2 Luye Pharma Group Overview
11.13.3 Luye Pharma Group Risperidone Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Luye Pharma Group Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Luye Pharma Group Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Risperidone Industry Chain Analysis
12.2 Risperidone Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Risperidone Production Mode & Process
12.4 Risperidone Sales and Marketing
12.4.1 Risperidone Sales Channels
12.4.2 Risperidone Distributors
12.5 Risperidone Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Risperidone Industry Trends
13.2 Risperidone Market Drivers
13.3 Risperidone Market Challenges
13.4 Risperidone Market Restraints
14 Key Findings in The Global Risperidone Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Risperidone Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Tablet
Table 3. Major Manufacturers of Oral Solution
Table 4. Global Risperidone Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Risperidone Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Risperidone Sales by Region (2017-2022) & (K Pcs)
Table 7. Global Risperidone Sales Market Share by Region (2017-2022)
Table 8. Global Risperidone Sales by Region (2023-2028) & (K Pcs)
Table 9. Global Risperidone Sales Market Share by Region (2023-2028)
Table 10. Global Risperidone Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Risperidone Revenue Market Share by Region (2017-2022)
Table 12. Global Risperidone Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Risperidone Revenue Market Share by Region (2023-2028)
Table 14. Global Risperidone Sales by Manufacturers (2017-2022) & (K Pcs)
Table 15. Global Risperidone Sales Share by Manufacturers (2017-2022)
Table 16. Global Risperidone Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Risperidone Revenue Share by Manufacturers (2017-2022)
Table 18. Risperidone Price by Manufacturers (2017-2022) &(US$/Pcs)
Table 19. Global Risperidone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Risperidone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Risperidone as of 2021)
Table 21. Risperidone Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Risperidone Product Offered
Table 23. Date of Manufacturers Enter into Risperidone Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Risperidone Sales by Type (2017-2022) & (K Pcs)
Table 26. Global Risperidone Sales by Type (2023-2028) & (K Pcs)
Table 27. Global Risperidone Sales Share by Type (2017-2022)
Table 28. Global Risperidone Sales Share by Type (2023-2028)
Table 29. Global Risperidone Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Risperidone Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Risperidone Revenue Share by Type (2017-2022)
Table 32. Global Risperidone Revenue Share by Type (2023-2028)
Table 33. Risperidone Price by Type (2017-2022) & (US$/Pcs)
Table 34. Global Risperidone Price Forecast by Type (2023-2028) & (US$/Pcs)
Table 35. Global Risperidone Sales by Application (2017-2022) & (K Pcs)
Table 36. Global Risperidone Sales by Application (2023-2028) & (K Pcs)
Table 37. Global Risperidone Sales Share by Application (2017-2022)
Table 38. Global Risperidone Sales Share by Application (2023-2028)
Table 39. Global Risperidone Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Risperidone Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Risperidone Revenue Share by Application (2017-2022)
Table 42. Global Risperidone Revenue Share by Application (2023-2028)
Table 43. Risperidone Price by Application (2017-2022) & (US$/Pcs)
Table 44. Global Risperidone Price Forecast by Application (2023-2028) & (US$/Pcs)
Table 45. North America Risperidone Sales by Type (2017-2022) & (K Pcs)
Table 46. North America Risperidone Sales by Type (2023-2028) & (K Pcs)
Table 47. North America Risperidone Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Risperidone Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Risperidone Sales by Application (2017-2022) & (K Pcs)
Table 50. North America Risperidone Sales by Application (2023-2028) & (K Pcs)
Table 51. North America Risperidone Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Risperidone Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Risperidone Sales by Country (2017-2022) & (K Pcs)
Table 54. North America Risperidone Sales by Country (2023-2028) & (K Pcs)
Table 55. North America Risperidone Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Risperidone Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Risperidone Sales by Type (2017-2022) & (K Pcs)
Table 58. Europe Risperidone Sales by Type (2023-2028) & (K Pcs)
Table 59. Europe Risperidone Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Risperidone Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Risperidone Sales by Application (2017-2022) & (K Pcs)
Table 62. Europe Risperidone Sales by Application (2023-2028) & (K Pcs)
Table 63. Europe Risperidone Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Risperidone Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Risperidone Sales by Country (2017-2022) & (K Pcs)
Table 66. Europe Risperidone Sales by Country (2023-2028) & (K Pcs)
Table 67. Europe Risperidone Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Risperidone Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Risperidone Sales by Type (2017-2022) & (K Pcs)
Table 70. Asia Pacific Risperidone Sales by Type (2023-2028) & (K Pcs)
Table 71. Asia Pacific Risperidone Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Risperidone Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Risperidone Sales by Application (2017-2022) & (K Pcs)
Table 74. Asia Pacific Risperidone Sales by Application (2023-2028) & (K Pcs)
Table 75. Asia Pacific Risperidone Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Risperidone Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Risperidone Sales by Region (2017-2022) & (K Pcs)
Table 78. Asia Pacific Risperidone Sales by Region (2023-2028) & (K Pcs)
Table 79. Asia Pacific Risperidone Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Risperidone Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Risperidone Sales by Type (2017-2022) & (K Pcs)
Table 82. Latin America Risperidone Sales by Type (2023-2028) & (K Pcs)
Table 83. Latin America Risperidone Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Risperidone Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Risperidone Sales by Application (2017-2022) & (K Pcs)
Table 86. Latin America Risperidone Sales by Application (2023-2028) & (K Pcs)
Table 87. Latin America Risperidone Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Risperidone Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Risperidone Sales by Country (2017-2022) & (K Pcs)
Table 90. Latin America Risperidone Sales by Country (2023-2028) & (K Pcs)
Table 91. Latin America Risperidone Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Risperidone Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Risperidone Sales by Type (2017-2022) & (K Pcs)
Table 94. Middle East and Africa Risperidone Sales by Type (2023-2028) & (K Pcs)
Table 95. Middle East and Africa Risperidone Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Risperidone Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Risperidone Sales by Application (2017-2022) & (K Pcs)
Table 98. Middle East and Africa Risperidone Sales by Application (2023-2028) & (K Pcs)
Table 99. Middle East and Africa Risperidone Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Risperidone Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Risperidone Sales by Country (2017-2022) & (K Pcs)
Table 102. Middle East and Africa Risperidone Sales by Country (2023-2028) & (K Pcs)
Table 103. Middle East and Africa Risperidone Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Risperidone Revenue by Country (2023-2028) & (US$ Million)
Table 105. Janssen (Johnson & Johnson) Corporation Information
Table 106. Janssen (Johnson & Johnson) Description and Major Businesses
Table 107. Janssen (Johnson & Johnson) Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 108. Janssen (Johnson & Johnson) Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Janssen (Johnson & Johnson) Recent Developments
Table 110. Ajanta Pharma Corporation Information
Table 111. Ajanta Pharma Description and Major Businesses
Table 112. Ajanta Pharma Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 113. Ajanta Pharma Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Ajanta Pharma Recent Developments
Table 115. Amneal Pharmaceuticals Corporation Information
Table 116. Amneal Pharmaceuticals Description and Major Businesses
Table 117. Amneal Pharmaceuticals Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 118. Amneal Pharmaceuticals Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Amneal Pharmaceuticals Recent Developments
Table 120. Aurobindo Pharma Corporation Information
Table 121. Aurobindo Pharma Description and Major Businesses
Table 122. Aurobindo Pharma Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 123. Aurobindo Pharma Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Aurobindo Pharma Recent Developments
Table 125. Hikma Corporation Information
Table 126. Hikma Description and Major Businesses
Table 127. Hikma Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 128. Hikma Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Hikma Recent Developments
Table 130. Sandoz Corporation Information
Table 131. Sandoz Description and Major Businesses
Table 132. Sandoz Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 133. Sandoz Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Sandoz Recent Developments
Table 135. Lannett Corporation Information
Table 136. Lannett Description and Major Businesses
Table 137. Lannett Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 138. Lannett Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Lannett Recent Developments
Table 140. Tris Pharma Corporation Information
Table 141. Tris Pharma Description and Major Businesses
Table 142. Tris Pharma Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 143. Tris Pharma Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Tris Pharma Recent Developments
Table 145. Apotex Corporation Information
Table 146. Apotex Description and Major Businesses
Table 147. Apotex Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 148. Apotex Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Apotex Recent Developments
Table 150. Celltrion Corporation Information
Table 151. Celltrion Description and Major Businesses
Table 152. Celltrion Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 153. Celltrion Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Celltrion Recent Developments
Table 155. Dr. Reddy's Laboratories Corporation Information
Table 156. Dr. Reddy's Laboratories Description and Major Businesses
Table 157. Dr. Reddy's Laboratories Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 158. Dr. Reddy's Laboratories Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Dr. Reddy's Laboratories Recent Developments
Table 160. Torrent Pharmaceuticals Corporation Information
Table 161. Torrent Pharmaceuticals Description and Major Businesses
Table 162. Torrent Pharmaceuticals Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 163. Torrent Pharmaceuticals Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Torrent Pharmaceuticals Recent Developments
Table 165. Luye Pharma Group Corporation Information
Table 166. Luye Pharma Group Description and Major Businesses
Table 167. Luye Pharma Group Risperidone Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 168. Luye Pharma Group Risperidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Luye Pharma Group Recent Developments
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Risperidone Distributors List
Table 173. Risperidone Customers List
Table 174. Risperidone Market Trends
Table 175. Risperidone Market Drivers
Table 176. Risperidone Market Challenges
Table 177. Risperidone Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Risperidone Product Picture
Figure 2. Global Risperidone Market Share by Type in 2021 & 2028
Figure 3. Tablet Product Picture
Figure 4. Oral Solution Product Picture
Figure 5. Global Risperidone Market Share by Application in 2021 & 2028
Figure 6. Schizophrenia
Figure 7. Bipolar Disorder
Figure 8. Risperidone Report Years Considered
Figure 9. Global Risperidone Sales 2017-2028 (K Pcs)
Figure 10. Global Risperidone Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Risperidone Revenue 2017-2028 (US$ Million)
Figure 12. Global Risperidone Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Risperidone Sales Market Share by Region (2017-2022)
Figure 14. Global Risperidone Sales Market Share by Region (2023-2028)
Figure 15. North America Risperidone Sales YoY (2017-2028) & (K Pcs)
Figure 16. North America Risperidone Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Risperidone Sales YoY (2017-2028) & (K Pcs)
Figure 18. Europe Risperidone Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Risperidone Sales YoY (2017-2028) & (K Pcs)
Figure 20. Asia-Pacific Risperidone Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Risperidone Sales YoY (2017-2028) & (K Pcs)
Figure 22. Latin America Risperidone Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Risperidone Sales YoY (2017-2028) & (K Pcs)
Figure 24. Middle East & Africa Risperidone Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Risperidone Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Risperidone in the World: Market Share by Risperidone Revenue in 2021
Figure 27. Global Risperidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Risperidone Sales Market Share by Type (2017-2028)
Figure 29. Global Risperidone Revenue Market Share by Type (2017-2028)
Figure 30. Global Risperidone Sales Market Share by Application (2017-2028)
Figure 31. Global Risperidone Revenue Market Share by Application (2017-2028)
Figure 32. North America Risperidone Sales Market Share by Type (2017-2028)
Figure 33. North America Risperidone Revenue Market Share by Type (2017-2028)
Figure 34. North America Risperidone Sales Market Share by Application (2017-2028)
Figure 35. North America Risperidone Revenue Market Share by Application (2017-2028)
Figure 36. North America Risperidone Sales Share by Country (2017-2028)
Figure 37. North America Risperidone Revenue Share by Country (2017-2028)
Figure 38. United States Risperidone Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Risperidone Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Risperidone Sales Market Share by Type (2017-2028)
Figure 41. Europe Risperidone Revenue Market Share by Type (2017-2028)
Figure 42. Europe Risperidone Sales Market Share by Application (2017-2028)
Figure 43. Europe Risperidone Revenue Market Share by Application (2017-2028)
Figure 44. Europe Risperidone Sales Share by Country (2017-2028)
Figure 45. Europe Risperidone Revenue Share by Country (2017-2028)
Figure 46. Germany Risperidone Revenue (2017-2028) & (US$ Million)
Figure 47. France Risperidone Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Risperidone Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Risperidone Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Risperidone Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Risperidone Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Risperidone Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Risperidone Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Risperidone Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Risperidone Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Risperidone Revenue Share by Region (2017-2028)
Figure 57. China Risperidone Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Risperidone Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Risperidone Revenue (2017-2028) & (US$ Million)
Figure 60. India Risperidone Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Risperidone Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Risperidone Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Risperidone Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Risperidone Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Risperidone Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Risperidone Sales Market Share by Type (2017-2028)
Figure 67. Latin America Risperidone Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Risperidone Sales Market Share by Application (2017-2028)
Figure 69. Latin America Risperidone Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Risperidone Sales Share by Country (2017-2028)
Figure 71. Latin America Risperidone Revenue Share by Country (2017-2028)
Figure 72. Mexico Ri
  • Global Divalproex Sodium Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 81
    Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in The brain tissue to stop seizures. Divalproex Sodium is also used to treat The manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches. This medicine is available only with your doctor's prescription. The global Divalproex Sodium market was valued at US$ 2188.5 million in 2023 and is anticipated to reach US$ 33......
  • Global Divalproex Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Divalproex Sodium market size was valued at US$ 2140.9 million in 2023. With growing demand in downstream market, the Divalproex Sodium is forecast to a readjusted size of US$ 3312 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Divalproex Sodium market. Divalproex Sodium are expected to show stable growth in the future market. However, product differ......
  • Global Quetiapine Fumarate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Quetiapine Fumarate market size was valued at US$ 156.2 million in 2023. With growing demand in downstream market, the Quetiapine Fumarate is forecast to a readjusted size of US$ 132.9 million by 2030 with a CAGR of -2.3% during review period. The research report highlights the growth potential of the global Quetiapine Fumarate market. Quetiapine Fumarate are expected to show stable growth in the future market. However, produ......
  • Global Clozapine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Clozapine market size was valued at US$ 341.4 million in 2023. With growing demand in downstream market, the Clozapine is forecast to a readjusted size of US$ 463.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Clozapine market. Clozapine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Trazodone Hydrochloride (API) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 92
    According to our LPI (LP Information) latest study, the global Trazodone Hydrochloride (API) market size was valued at US$ million in 2023. With growing demand in downstream market, the Trazodone Hydrochloride (API) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Trazodone Hydrochloride (API) market. Trazodone Hydrochloride (API) are expected to show stable growth in the future......
  • Global Trazodone Hydrochloride (API) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 93
    According to our (Global Info Research) latest study, the global Trazodone Hydrochloride (API) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Trazodone, a phenylpiperazine-triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety an......
  • Global Divalproex Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Divalproex Sodium market size was valued at USD 2251.9 million in 2023 and is forecast to a readjusted size of USD 3371.1 million by 2030 with a CAGR of 5.9% during review period. Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in the brain tissue to stop seizures. Divalproex Sodium is also used to treat the manic phase of bipolar disorder (manic-d......
  • Global Risperidone Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 93
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Risperidone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Janssen (Johnson & Johnson) - Ajanta Pharma - Amneal Pharmaceuticals - Aurobindo Pharma - Hikma - Sandoz - Lannett - Tris Pharma - Ap......
  • Global Schizophrenia Therapeutics Market Status and Outlook 2023-2028
    Published: 27-Dec-2023        Price: US 3160 Onwards        Pages: 101
    Schizophrenia is usually treated with an individually tailored combination of talking therapy and medicine. Most people with schizophrenia are treated by community mental health teams (CMHTs). The goal of the CMHT is to provide day-to-day support and treatment while ensuring you have as much independence as possible. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market va......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs